Actipulse Neuroscience
Actipulse Neuroscience is a healthcare company specializing in non-invasive brain stimulation devices for treating CNS disorders, with a focus on depression, Alzheimer's, and Parkinson's diseases.
Company Overview
Actipulse Neuroscience is a healthcare company specializing in the development of non-invasive brain stimulation devices. Founded to make advanced medical technologies more accessible and affordable, the company is actively involved in clinical research focusing on Central Nervous System (CNS) disorders. Actipulse Neuroscience is a pioneer in transcranial neuromodulation devices that use high-frequency magnetic pulses to target multiple pathogenic mechanisms in neurodegenerative disorders. With a team of 30 professionals, the company operates in multiple regions including Mexico, Latin America, and partly remote locations. The global headquarters is situated at 210 Broadway, Cambridge, MA.
Clinical Research and Development
Actipulse Neuroscience focuses on clinical research for Non-Invasive Brain Stimulation (NIBS) technologies aimed at treating CNS disorders. The company is in the FDA pivotal phase for a device intended for the home treatment of Major Depressive Disorder. Additionally, Actipulse is in the pilot phase for treating Alzheimer's and Parkinson's diseases. Their clinical pipeline includes a Phase 3 pivotal study for Major Depressive Disorder, with an aim to become the gold standard in neuromodulation technologies within the next five years.
Innovative Medical Devices
Actipulse Neuroscience has developed a proprietary brain stimulation device designed for non-invasive treatments. This device utilizes high-frequency magnetic pulses for transcranial neuromodulation, providing a cutting-edge solution for various neurodegenerative disorders. The device is currently undergoing rigorous clinical trials, including pivotal FDA studies, to validate its efficacy and safety for treating Major Depressive Disorder, as well as pilot programs for Alzheimer's and Parkinson's diseases.
Global Presence
Actipulse Neuroscience operates globally with offices in Mexico City, Paris, and Cambridge, MA. The company serves multiple regions including Mexico, Latin America, and partly remote areas, leveraging its strategic locations to conduct extensive clinical research and reach a diverse patient population. Actipulse’s global headquarters, located at 210 Broadway, Cambridge, MA, functions as the central hub for its international operations and research activities.
Y Combinator Backing
Actipulse Neuroscience is backed by Y Combinator, having participated in the W22 batch. This prestigious accelerator program supports the company’s initiatives to develop and commercialize innovative medical devices. Through Y Combinator, Actipulse has gained valuable resources, mentorship, and networking opportunities to further its mission of advancing non-invasive brain stimulation technologies.